ClinicalThought

Share

Program Content

Activities

  • Frontline Therapy in CLL
    What’s New Regarding Frontline Combination Regimens in CLL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 03, 2019

    Expires: May 01, 2020

  • ASCO 2019 Data in CLL
    My Take on New Advances in CLL From ASCO 2019
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 27, 2019

    Expires: June 25, 2020

  • Updated CLL Tool
    CLL Is Evolving and the Treatment Decision Support Tool Is Keeping Pace
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 13, 2019

    Expires: November 11, 2020

  • Acalabrutinib in CLL
    My Thoughts on the Recent FDA Approval of Acalabrutinib in CLL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 10, 2020

    Expires: January 08, 2021

Faculty

cover img faculity

Farrukh Awan, MD, MS

Associate Professor of Internal Medicine
Division of Hematology
The Ohio State University Comprehensive Cancer Center
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Columbus, Ohio

cover img faculity

Ian Flinn, MD, PhD

Chief Scientific Officer
OneOncology
Nashville, Tennessee

cover img faculity

Nicole Lamanna, MD

Associate Professor
Leukemia Service
Director of CLL Program
Hematologic Malignancies Section
Department of Medicine
New York-Presbyterian/Columbia University Medical Center
New York, New York

Provided by

ProCE Banner

Supporters

AbbVie

AstraZeneca

Pharmacyclics AbbVie

Verastem Oncology

Partners

CLL Society

ProCE Banner